What is Knight Therapeutics Price-to-Operating-Cash-Flow?
As of today (2024-05-05), Knight Therapeutics's share price is C$5.91.
Knight Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.33. Hence, Knight Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is 17.69.
The historical rank and industry rank for Knight Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:
TSX:GUD'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.58 Med: 44.07 Max: 2813.33
Current: 17.69
During the past 11 years, Knight Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 2813.33. The lowest was 11.58. And the median was 44.07.
Knight Therapeutics's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was C$0.17.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.33.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Knight Therapeutics was -14.80% per year.
During the past 11 years, Knight Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 128.20% per year. The lowest was -35.30% per year. And the median was 127.10% per year.
Knight Therapeutics Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Knight Therapeutics's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Knight Therapeutics Price-to-Operating-Cash-Flow Chart
|
Knight Therapeutics Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
229.70 |
- |
14.80 |
13.21 |
15.54 |
|
Knight Therapeutics Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
13.21 |
14.19 |
27.29 |
20.45 |
15.54 |
Competitive Comparison of Knight Therapeutics's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Knight Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Knight Therapeutics's Price-to-Operating-Cash-Flow falls into.
Knight Therapeutics Price-to-Operating-Cash-Flow Calculation
Knight Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 5.91 | / | 0.334 |
| = | 17.69 |
Knight Therapeutics's Share Price of today is C$5.91.
Knight Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.33.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Knight Therapeutics (TSX:GUD) Business Description
Traded in Other Exchanges
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Executives
Knight Therapeutics (TSX:GUD) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:GUD has been successfully added to your